We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.68B
AUM Growth
+$4.27B
Cap. Flow
+$4.13B
Cap. Flow %
61.82%
Top 10 Hldgs %
13.41%
Holding
935
New
392
Increased
185
Reduced
81
Closed
253

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$84.6M
2
MCD icon
McDonald's
MCD
+$79.3M
3
BBY icon
Best Buy
BBY
+$78M
4
SPGI icon
S&P Global
SPGI
+$75.1M
5
DGX icon
Quest Diagnostics
DGX
+$73.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.81%
2 Healthcare 17.75%
3 Technology 12.65%
4 Financials 8.92%
5 Consumer Staples 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
601
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$396K 0.01%
+7,644
New +$414K
PEB icon
602
Pebblebrook Hotel Trust
PEB
$2.16B
$395K 0.01%
+10,184
New +$383K
ASHR icon
603
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
$392K 0.01%
+14,761
New +$438K
VTLE
604
DELISTED
Vital Energy
VTLE
$387K 0.01%
+2,011
New +$377K
AGN
605
DELISTED
Allergan plc
AGN
$383K 0.01%
+2,295
New +$368K
UTHR icon
606
United Therapeutics
UTHR
$26.3B
$376K 0.01%
+3,327
New +$366K
GWR
607
DELISTED
Genesee & Wyoming Inc.
GWR
$374K 0.01%
+4,602
New +$349K
TSC
608
DELISTED
TriState Capital Holdings, Inc.
TSC
$373K 0.01%
+14,300
New +$362K
GGAL icon
609
Galicia Financial Group
GGAL
$7.92B
$372K 0.01%
+11,266
New +$579K
CHRS icon
610
Coherus Oncology
CHRS
$217M
$369K 0.01%
+26,358
New +$377K
DXJ icon
611
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
$369K 0.01%
+6,834
New +$387K
RWX icon
612
State Street SPDR Dow Jones International Real Estate ETF
RWX
$265M
$367K 0.01%
+9,372
New +$376K
COP icon
613
ConocoPhillips
COP
$147B
$366K 0.01%
5,263
-208,789
-98% -$13.9M
VEA icon
614
Vanguard FTSE Developed Markets ETF
VEA
$226B
$365K 0.01%
+8,500
New +$379K
AGR
615
DELISTED
Avangrid, Inc.
AGR
$358K 0.01%
+6,773
New +$350K
VCR icon
616
Vanguard Consumer Discretionary ETF
VCR
$5.84B
$350K 0.01%
2,066
-58
-3% -$9.58K
TECK icon
617
Teck Resources
TECK
$29.5B
$344K 0.01%
+13,506
New +$362K
MCHP icon
618
Microchip Technology
MCHP
$42.8B
$341K 0.01%
+7,500
New +$348K
CIR
619
DELISTED
CIRCOR International, Inc
CIR
$340K 0.01%
+9,202
New +$414K
AJG icon
620
Arthur J. Gallagher & Co
AJG
$63.7B
$336K 0.01%
5,141
-226,959
-98% -$15.4M
KMI icon
621
Kinder Morgan
KMI
$73.1B
$336K 0.01%
+19,015
New +$311K
TWLO icon
622
Twilio
TWLO
$29.1B
$336K 0.01%
+6,000
New +$297K
BMRN icon
623
BioMarin Pharmaceuticals
BMRN
$11.5B
$328K ﹤0.01%
3,480
-4,729
-58% -$414K
BBD icon
624
Banco Bradesco
BBD
$38.1B
$326K ﹤0.01%
75,838
+49,516
+188% +$269K
CHRW icon
625
C.H. Robinson
CHRW
$22B
$326K ﹤0.01%
3,896
-50,634
-93% -$4.52M

Similar funds

Marshall Wace's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace held 935 positions worth $6.68B, up 177% from $2.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.13B of net new capital in Q2 2018, opening 392 new positions and adding to 185 existing holdings. Its largest new stake was TSMC: 1,597,877 shares worth $58.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alibaba, an estimated $79.1M trimmed.

  • Marshall Wace's largest Q2 2018 buy was TSMC: 1,597,877 shares worth $58.4M.
  • Marshall Wace added most to Teleflex in Q2 2018, an estimated $84.6M increase.
  • Marshall Wace's biggest Q2 2018 reduction was Alibaba, cutting an estimated $79.1M.
  • Marshall Wace fully exited Monsanto Co in Q2 2018, selling an estimated $59.9M.
  • Marshall Wace's ten largest holdings make up 13% of its $6.68B portfolio in Q2 2018.
  • Marshall Wace opened 392 new positions and closed 253 in Q2 2018.
  • Marshall Wace's portfolio value rose 177% quarter-over-quarter to $6.68B.

Based on Marshall Wace's 13F filing for Q2 2018, filed 14 Aug 2018.